Hépatite C en pratique transfusionnelle

Jullien, A

doi:10.1016/s0399-077x(05)80897-2

Médecine et Maladies Infectieuses

1995

DOI: 10.1016/s0399-077x(05)80897-2

|View full text |Cite

Hépatite C en pratique transfusionnelle

A Jullien

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1996

1997

Publication Types

Select...

Article2

Relationship

Self Cite0

Independent2

Authors

Journals

Cited by 2 publications

References 79 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Magnitude and management of HCV infection in France

Trépo¹,

Bailly²

1996

Digest Dis Sci

View full text Add to dashboard Cite

The prevalence of hepatitis C virus infection in the general population in France averages 1%. The majority of these patients are viremic with detectable HCV-RNA. Further, 75% of these individuals did not suspect they were at risk for being HCV carriers. Less than 10% of HCV carriers in France have been identified and even fewer have been treated with interferon. In addition to infection following intravenous drug use, preliminary studies suggest that most newly infected patients have become infected following surgery or endoscopy without transfusion. A large serological study of patients scheduled for surgery identified 4% HCV carriers. Other studies have determined that more than 8% of patients who received prior transfusions are now anti-HCV positive. These findings prompted the French government to initiate a screening program in France to identify patients at risk for HCV infection. This national program also involves the establishment of regional HCV reference centers to coordinate efforts among hospitals, gastroenterology/hepatology specialists, and general practitioners. The mission of the program is to promote screening and disseminate appropriate clinical practice guidelines for the management of HCV infection. The goal is to identify infected patients and initiate optimal interferon therapy as early as possible in the course of HCV infection to prevent the long-term complications secondary to infection.

show abstract

Magnitude and management of HCV infection in France

Trépo¹,

Bailly²

1996

Digest Dis Sci

View full text Add to dashboard Cite

show abstract

Épidémiologie descriptive de l'infection par le virus de l'hépatite C en France en 1996

Lefrère

1997

Transfusion Clinique et Biologique

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Hépatite C en pratique transfusionnelle

Cited by 2 publications

References 79 publications

Magnitude and management of HCV infection in France

Magnitude and management of HCV infection in France

Épidémiologie descriptive de l'infection par le virus de l'hépatite C en France en 1996

Contact Info

Product

Resources

About